Market Tracker

06/24 4:19pm ET

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

1.54
Delayed Data
As of 4:00pm ET
 -0.13 / -7.78%
Today’s Change
1.23
Today|||52-Week Range
20.45
-84.75%
Year-to-Date

Today’s Trading

Previous close1.67
Today’s open1.57
Day’s range1.52 - 1.69
Volume2,527,946
Average volume (3 months)939,391
Market cap$47.8M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-88.89%
Earnings growth (this year)-45.98%
Earnings growth (next 5 years)+15.84%
Revenue growth (last year)+51.47%
P/E ratioNM
Price/Sales1.21
Price/Book0.41

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc-0.03-2.24%
PZRXPhaseRx Inc-0.60-12.90%
FATEFate Therapeutics In...+0.06+3.28%
CANFCan Fite Biopharma L...-0.07-2.62%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$239.9M
Annual profit (last year)-$73.3M
Net profit margin-30.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts